Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 16, 2010
Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes--an application of marginal structural modelsAndrew P Yu, Yanni F Yu, Michael B Nichol
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 11, 2005
Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid programYanni F Yu, Michael B Nichol, Andrew P Yu, et al.
Postgraduate Medicine|February 9, 2012
Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugsMorgan Bron, Maryna Marynchenko, Hongbo Yang, et al.
Journal of Medical Economics|July 7, 2011
Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancerHongbo Yang, Andrew P Yu, Eric Q Wu, et al.
Journal of Medical Economics|April 20, 2011
Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysisAndrew P Yu, Hongbo Yang, Eric Q Wu, et al.
American Journal of Therapeutics|February 15, 2011
Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapyEric Q Wu, Anna Forsythe, Annie Guérin, et al.
Annals of Vascular Surgery|June 29, 2010
Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial diseaseMichael R Jaff, Kevin E Cahill, Andrew P Yu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid populationAndrew P Yu, Pavel Atanasov, Rym Ben-Hamadi, et al.
Managed Care (Langhorne, Pa.)|February 16, 2012
Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid populationEric Q Wu, Rym Ben-Hamadi, Mei Lu, et al.
Current Medical Research and Opinion|February 10, 2009
Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid populationAndrew P Yu, Rym Ben-Hamadi, Howard G Birnbaum, et al.
Pageof 6